Li Li, MD, PhD

Special Interests

The majority of Dr. Li’s current research is a) to define the specific CBD and sarcoidosis disease gene profiles and their function, b) to investigate the potential molecular and immunopathogenetic mechanisms suggested by these studies, and c) to identify possible surrogate biomarkers of CBD and sarcoidosis in the future. She strongly believe that by revealing the mechanisms of the granulomatous diseases, it will not only aid in the prevention or early diagnosis of CBD and sarcoidosis, but also provide insights into the potential therapeutic applications.  It is also her goal to extend the results of the biomarker investigation by testing its application for use as a future clinical diagnostic.

Education

Education

2002 - 2005

University of Ulm, Department of Internal Medicine, Ulm

2001 - 2004

Tongji Medical College, Huazhong University of Science & Technology, Wuhan, P.R.

1996 - 1999

Tongji Medical University, Wuhan, P.R.

1991 - 1996

China Medical University, Shenyang, P.R.

Fellowship

2006 - 2007

University of Colorado at Denver and Health Sciences Center, Department of Dermatology, Denver, Colorado

Awards & Recognition

2007: Society of Investigative Dermatology, Eugene M. Farber Travel Award for Young Investigators

Professional Memberships

2008-present: ATS

Academic Affiliations

Division of Pulmonary and Critical Care Sciences, Department of Medicine, School of Medicine